Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
890 Nivolumab plus ipilimumab in anti-PD(L)-1 naïve and experienced HCC patients — single institute experience in Taiwan
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 890 Nivolumab plus ipilimumab in anti-PD(L)-1 naïve and experienced HCC patients — single institute experience in Taiwan